Treating Claudin18.2-positive Advanced Solid Tumors with XKDCT225(Targeting Claudin18.2-CAR-T)

Clinical trial NCT06782425 · RECRUITING

Trial details

NCT number: NCT06782425
Sponsor: Shenzhen Celconta Life Science Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Claudin18.2 Positive Advanced Solid Tumors

Start date: 2025-01-01
Primary completion: 2028-01-01
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.